Our challenge is of a different scale than any experienced before

It’s not only about protecting our planet

It’s about protecting life

Planet Mobilization is our global effort to minimize the environmental impact of our business through environmental sustainability. It covers the entire life cycle of the products, from the raw materials used to make them to their use and disposal by our patients.

Ahead of the UN climate change conference, the COP26 this November, we’ve joined the Race to Zero initiative, a global commitment to net zero carbon emissions by 2050.

Targeting our Global Suppliers with ENERGIZE

We’re uniting with nine global pharmaceutical companies to help our shared supply chains adopt 100% renewable electricity and reduce greenhouse gas emissions. Reducing global warming is not something any of us can do on our own. The ENERGIZE program members-AstraZeneca, Biogen, GSK, Johnson & Johnson, Merck, Novartis, NovoNordisk, Pfizer and Takeda-will support suppliers reduce Scope 2 greenhouse gas emissions, i.e., the electricity we buy, which in turn will reduce our Scope 3 emissions, those that occur throughout the value chain such as transportation and distribution. If you are a supplier and would like to find out more about the Energize program click here: https://neonetworkexchange.com/energize.

We’re pursuing these three goals:

1
Reach carbon neutrality* by 2030
2
Limit our environmental footprint and adopt circular solutions
3
Improve environmental profile of our products

Climate change is one, if not the greatest, challenge of our age

It has an enormous impact on our lives and health. The rise in the earth’s temperature can lead to extreme weather conditions, food shortages, difficulties in accessing drinking water and increased air pollution, as well as creating favorable conditions for the spread of vector-borne diseases such as malaria or increasing pollen-related allergies.

The World Health Organization (WHO) estimates that between 2030 and 2050 climate change will cause an estimated 250,000 additional deaths each year. To limit the consequences of global warming, the United Nations presents carbon neutrality as the solution to counterbalance the buildup of greenhouse gas emissions in our atmosphere.

Here's how we're measuring our progress

Someone putting water on a young plant
Employees do More to Protect the Planet

Meet the Tribe, a 2,000-strong employee network whose energy and creativity are driving new ways to make Sanofi’s sites and activities environmentally sustainable

CDP 2020 Ratings

Sanofi gained a place on the CDP’s prestigious “A List” for its role in protecting water resources. It also obtained an A- for its reduction in greenhouse gas emissions, reaffirming its position in the leadership group of companies evaluated.

Committed to 100% Renewable Electricity

Sanofi joined the RE100 initiative to source 100% renewable electricity across all its global operations by 2030

Reducing Greenhouse Gas Emissions

In June 2020, Sanofi received approval from the “Science Based Targets initiative” (SBTi) for setting science-based targets to reduce absolute greenhouse gas (GHG) emissions

Sanofi pioneers sustainable finance in the pharmaceutical industry

Sanofi signs its two first sustainability-linked revolving credit facilities

Committed to 100% Renewable Electricity

In France, all Sanofi sites are now powered by 100% renewable electricity

Our Commitments and Targets

Sanofi's Achievements

References

* Carbon neutrality is achieved when company emissions of greenhouse gases in the atmosphere are balanced by reduction or avoidance elsewhere over a specified period. We have increased our ambition to achieve carbon neutrality 20 years earlier than our previous 2015 commitment, made after the COP21 and Paris Agreement. We have also widened this ambition to our whole value chain (scopes 1, 2 and 3).